WHY IT MATTERS: If you are currently using a CBD isolate product and not experiencing the relief you expected, the entourage effect suggests that switching to a full-spectrum formulation containing multiple cannabinoids and terpenes may provide meaningfully better results. CLINICAL OVERVIEW: The entourage effect describes how the full spectrum of cannabinoids, terpenes, and flavonoids in the cannabis plant work synergistically to produce therapeutic outcomes that isolated compounds alone cannot replicate. In clinical practice, patients using whole-plant or full-spectrum formulations frequently report more robust and nuanced symptom relief compared to those using single-molecule isolates like pure CBD or pure THC.
Hawaii Senators Approve Limited Marijuana Legalization Bill After House Punts for 2026
A cannabis beverage brand sponsoring a major NBA arena signals that these products are becoming as mainstream as beerโyet the federal ban could eliminate them just as they achieve cultural acceptance. Hawaii senators have taken up a pair of bills to legalize marijuana, with one proposal contingent on federal reform or changes to the state Constitution. The Senate’s advancement comes after the House punted on reform for 2026.
The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by acti
Rheumatoid arthritis (RA) is a very common chronic disease affecting many joints, most noticeably those in the hands and feet. It occurs when the bodyโs immune system attacks its own tissues that...
A Cannabinoid-Like Compound Modulates Neuronal Excitability, May Reduce Seizures
The Cannabinoid-Like Compound, VSN16R, Acts on Large Conductance, Ca2 -Activated K Channels to Modulate Hippocampal CA1 Pyramidal Neuron Firing In Summary Researchers have recently found a cannabinoid-like compound, VSN16R, which is able...
Cannabinoids: A new hope for breast cancer therapy?
Breast cancer is one of the most common cancers, affecting approximately 1 in 10 women at some points in their lives. Although the rates of mortality have declined since the late 1990s,...
The potential application of the cannabinoid Beta-caryophyllene in glioblastoma therapy
Beta-Caryophyllene Inhibits Cell Proliferation through a Direct Modulation of CB2 Receptors in Glioblastoma Cells โIn Summary Glioblastoma (GBM) is an aggressive type of cancer of the brain and spinal cord, arising from...
Cannabinoid receptor type 2 as a promising new target for schizophrenia drugs
Contribution of CB2 receptors in schizophrenia-related symptoms in various animal models โIn Summary Schizophrenia is a serious, chronic mental disorder that disrupts how a person thinks, feels and behaves. Its psychotic (also...
FDA hesitant to approve more CBD based products
FDA Warns of Potential Harm From CBD Products In Summary The spread of misinformation is one of the scariest things in the 21st century. As more and more people become exposed to...
(โ)-ร-Caryophyllene, a Terpine Found in Cannabis, Demonstrates Therapeutic Potential in a Mouse Model of MS
(โ)-ฮฒ-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis In Summary Multiple sclerosis (MS) is a central nervous system disease whose inflammatory and other...
Pain, pleasure, and placebo: Cannabinoids in reward processing and the perception of pain
Cannabinoids could be a tool to reduce opioid doses when treating chronic pain โ When treating chronic pain, there is a constant dilemma between adequately relieving pain while also preventing addiction to...